Patents Assigned to ICB Pharma
  • Patent number: 11589580
    Abstract: The invention relates to pesticidal compositions comprising trisiloxane surfactants and a matrix-forming agent, which compositions are capable of controlling pests and pathogens using a physical mode of action. Accordingly, in one aspect, the present disclosure provides a pesticidal composition for controlling pests and pathogens with a physical mode of action. The composition comprises trisiloxane surfactants and matrix-forming agents. The composition may form a gel matrix or a film matrix. The trisiloxane surfactants may be selected from the group consisting of Silwet L-77, Silwet 408, Break-Thru S-240, and Silibase 2848. The matrixforming agents of a pesticidal composition are selected from the group consisting of chitosan salts and sol-gel precursors.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: February 28, 2023
    Assignee: ICB PHARMA
    Inventors: Janusz Swietoslawski, Wojciech Wieczorek, Dawid Liszka
  • Publication number: 20170238537
    Abstract: The invention relates to pesticidal compositions comprising trisiloxane surfactants and a matrix-forming agent, which compositions are capable of controlling pests and pathogens using a physical mode of action. Accordingly, in one aspect, the present disclosure provides a pesticidal composition for controlling pests and pathogens with a physical mode of action. The composition comprises trisiloxane surfactants and matrix-forming agents. The composition may form a gel matrix or a film matrix. The trisiloxane surfactants may be selected from the group consisting of Silwet L-77, Silwet 408, Break-Thru S-240, and Silibase 2848. The matrixforming agents of a pesticidal composition are selected from the group consisting of chitosan salts and sol-gel precursors.
    Type: Application
    Filed: October 14, 2015
    Publication date: August 24, 2017
    Applicant: ICB PHARMA
    Inventors: Janusz Swietoslawski, Wojciech Wieczorek, Dawid Liszka
  • Patent number: D650464
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: December 13, 2011
    Assignee: ICB Pharma
    Inventor: Tomasz Świȩtoslawski
  • Patent number: D650882
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: December 20, 2011
    Assignee: ICB Pharma
    Inventor: Tomasz Świȩtoslawski
  • Patent number: D650883
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: December 20, 2011
    Assignee: ICB Pharma
    Inventor: Tomasz Świȩtoslawski